Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
US Army
Baxter
Chinese Patent Office
Merck
Cantor Fitzgerald
Fuji
Cerilliant
Boehringer Ingelheim
Julphar

Generated: January 17, 2018

DrugPatentWatch Database Preview

THEOLAIR-SR Drug Profile

« Back to Dashboard

Which patents cover Theolair-sr, and when can generic versions of Theolair-sr launch?

Theolair-sr is a drug marketed by 3M and is included in four NDAs.

The generic ingredient in THEOLAIR-SR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the theophylline profile page.

US Patents and Regulatory Information for THEOLAIR-SR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m THEOLAIR-SR theophylline TABLET, EXTENDED RELEASE;ORAL 088369-001 Jul 16, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m THEOLAIR-SR theophylline TABLET, EXTENDED RELEASE;ORAL 089132-001 Jul 16, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m THEOLAIR-SR theophylline TABLET, EXTENDED RELEASE;ORAL 086363-002 Jul 16, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m THEOLAIR-SR theophylline TABLET, EXTENDED RELEASE;ORAL 088364-001 Jul 16, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Dow
US Army
Queensland Health
Deloitte
Citi
Colorcon
Johnson and Johnson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot